Cervical cancer incidence after up to 20 years of observation among women with HIV

L. Stewart Massad, Nancy A. Hessol, Teresa M. Darragh, Howard Minkoff, Christine Colie, Rodney L. Wright, Mardge Cohen, Eric Carl Seaberg

Research output: Contribution to journalArticle

Abstract

To estimate the incidence of invasive cervical cancer (ICC) across up to 21 years of follow-up among women with human immunodeficiency virus (HIV) and to compare it to that among HIV-uninfected women, we reviewed ICC diagnoses from a 20-year multi-site U.S. cohort study of HIV infected and uninfected women who had Pap testing every 6 months. Incidence rates were calculated and compared to those in HIV-negative women. Incidence ratios standardized to age-, sex-, race-, and calendar-year specific population rates were calculated. After a median follow-up of 12.3 years, four ICCs were confirmed in HIV seropositive women, only one in the last 10 years of observation, and none in seronegative women. The ICC incidence rate did not differ significantly by HIV status (HIV seronegative: 0/100,000 person-years vs. HIV seropositive: 19.5/100,000 person-years; p = 0.53). The standardized incidence ratio for the HIV-infected WIHS participants was 3.31 (95% CI: 0.90, 8.47; p = 0.07). Although marginally more common in women without HIV, for those with HIV in a prevention program, ICC does not emerge as a major threat as women age.

Original languageEnglish (US)
Pages (from-to)1561-1565
Number of pages5
JournalInternational Journal of Cancer
Volume141
Issue number8
DOIs
StatePublished - Oct 15 2017

Fingerprint

Uterine Cervical Neoplasms
Observation
HIV
Incidence
Cohort Studies

Keywords

  • cancer prevention
  • cervical cancer
  • HIV in women

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Massad, L. S., Hessol, N. A., Darragh, T. M., Minkoff, H., Colie, C., Wright, R. L., ... Seaberg, E. C. (2017). Cervical cancer incidence after up to 20 years of observation among women with HIV. International Journal of Cancer, 141(8), 1561-1565. https://doi.org/10.1002/ijc.30866

Cervical cancer incidence after up to 20 years of observation among women with HIV. / Massad, L. Stewart; Hessol, Nancy A.; Darragh, Teresa M.; Minkoff, Howard; Colie, Christine; Wright, Rodney L.; Cohen, Mardge; Seaberg, Eric Carl.

In: International Journal of Cancer, Vol. 141, No. 8, 15.10.2017, p. 1561-1565.

Research output: Contribution to journalArticle

Massad, LS, Hessol, NA, Darragh, TM, Minkoff, H, Colie, C, Wright, RL, Cohen, M & Seaberg, EC 2017, 'Cervical cancer incidence after up to 20 years of observation among women with HIV', International Journal of Cancer, vol. 141, no. 8, pp. 1561-1565. https://doi.org/10.1002/ijc.30866
Massad LS, Hessol NA, Darragh TM, Minkoff H, Colie C, Wright RL et al. Cervical cancer incidence after up to 20 years of observation among women with HIV. International Journal of Cancer. 2017 Oct 15;141(8):1561-1565. https://doi.org/10.1002/ijc.30866
Massad, L. Stewart ; Hessol, Nancy A. ; Darragh, Teresa M. ; Minkoff, Howard ; Colie, Christine ; Wright, Rodney L. ; Cohen, Mardge ; Seaberg, Eric Carl. / Cervical cancer incidence after up to 20 years of observation among women with HIV. In: International Journal of Cancer. 2017 ; Vol. 141, No. 8. pp. 1561-1565.
@article{8f6799ae820344e5a752437a3865e284,
title = "Cervical cancer incidence after up to 20 years of observation among women with HIV",
abstract = "To estimate the incidence of invasive cervical cancer (ICC) across up to 21 years of follow-up among women with human immunodeficiency virus (HIV) and to compare it to that among HIV-uninfected women, we reviewed ICC diagnoses from a 20-year multi-site U.S. cohort study of HIV infected and uninfected women who had Pap testing every 6 months. Incidence rates were calculated and compared to those in HIV-negative women. Incidence ratios standardized to age-, sex-, race-, and calendar-year specific population rates were calculated. After a median follow-up of 12.3 years, four ICCs were confirmed in HIV seropositive women, only one in the last 10 years of observation, and none in seronegative women. The ICC incidence rate did not differ significantly by HIV status (HIV seronegative: 0/100,000 person-years vs. HIV seropositive: 19.5/100,000 person-years; p = 0.53). The standardized incidence ratio for the HIV-infected WIHS participants was 3.31 (95{\%} CI: 0.90, 8.47; p = 0.07). Although marginally more common in women without HIV, for those with HIV in a prevention program, ICC does not emerge as a major threat as women age.",
keywords = "cancer prevention, cervical cancer, HIV in women",
author = "Massad, {L. Stewart} and Hessol, {Nancy A.} and Darragh, {Teresa M.} and Howard Minkoff and Christine Colie and Wright, {Rodney L.} and Mardge Cohen and Seaberg, {Eric Carl}",
year = "2017",
month = "10",
day = "15",
doi = "10.1002/ijc.30866",
language = "English (US)",
volume = "141",
pages = "1561--1565",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "8",

}

TY - JOUR

T1 - Cervical cancer incidence after up to 20 years of observation among women with HIV

AU - Massad, L. Stewart

AU - Hessol, Nancy A.

AU - Darragh, Teresa M.

AU - Minkoff, Howard

AU - Colie, Christine

AU - Wright, Rodney L.

AU - Cohen, Mardge

AU - Seaberg, Eric Carl

PY - 2017/10/15

Y1 - 2017/10/15

N2 - To estimate the incidence of invasive cervical cancer (ICC) across up to 21 years of follow-up among women with human immunodeficiency virus (HIV) and to compare it to that among HIV-uninfected women, we reviewed ICC diagnoses from a 20-year multi-site U.S. cohort study of HIV infected and uninfected women who had Pap testing every 6 months. Incidence rates were calculated and compared to those in HIV-negative women. Incidence ratios standardized to age-, sex-, race-, and calendar-year specific population rates were calculated. After a median follow-up of 12.3 years, four ICCs were confirmed in HIV seropositive women, only one in the last 10 years of observation, and none in seronegative women. The ICC incidence rate did not differ significantly by HIV status (HIV seronegative: 0/100,000 person-years vs. HIV seropositive: 19.5/100,000 person-years; p = 0.53). The standardized incidence ratio for the HIV-infected WIHS participants was 3.31 (95% CI: 0.90, 8.47; p = 0.07). Although marginally more common in women without HIV, for those with HIV in a prevention program, ICC does not emerge as a major threat as women age.

AB - To estimate the incidence of invasive cervical cancer (ICC) across up to 21 years of follow-up among women with human immunodeficiency virus (HIV) and to compare it to that among HIV-uninfected women, we reviewed ICC diagnoses from a 20-year multi-site U.S. cohort study of HIV infected and uninfected women who had Pap testing every 6 months. Incidence rates were calculated and compared to those in HIV-negative women. Incidence ratios standardized to age-, sex-, race-, and calendar-year specific population rates were calculated. After a median follow-up of 12.3 years, four ICCs were confirmed in HIV seropositive women, only one in the last 10 years of observation, and none in seronegative women. The ICC incidence rate did not differ significantly by HIV status (HIV seronegative: 0/100,000 person-years vs. HIV seropositive: 19.5/100,000 person-years; p = 0.53). The standardized incidence ratio for the HIV-infected WIHS participants was 3.31 (95% CI: 0.90, 8.47; p = 0.07). Although marginally more common in women without HIV, for those with HIV in a prevention program, ICC does not emerge as a major threat as women age.

KW - cancer prevention

KW - cervical cancer

KW - HIV in women

UR - http://www.scopus.com/inward/record.url?scp=85024885906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85024885906&partnerID=8YFLogxK

U2 - 10.1002/ijc.30866

DO - 10.1002/ijc.30866

M3 - Article

VL - 141

SP - 1561

EP - 1565

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 8

ER -